The Technical Analyst
Select Language :
Selecta Biosciences Inc [SELB]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Selecta Biosciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Selecta Biosciences Inc is listed at the  Exchange

-8.00% $0.881

America/New_York / 13 nov 2023 @ 16:00


Selecta Biosciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 135.20 mill
EPS: -0.290
P/E: -3.04
Earnings Date: Nov 12, 2023
SharesOutstanding: 153.43 mill
Avg Daily Volume: 0.634 mill
RATING 2023-12-11
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/a
Gr.Profitn/a
Ebitn/a
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.04 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.52x
Company: PE -3.04 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.571 - 0.763

( +/- 14.39%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-02 Singer Michael Buy 178 000 Common Stock
2024-01-02 Singer Michael Buy 228 000 Stock Option (Right to Buy)
2023-12-22 Singer Michael Sell 3 000 Series A Convertible Preferred Stock
2024-01-02 Davis Blaine Buy 3 110 000 Employee Stock Option (right to buy)
2024-01-02 Davis Blaine Buy 2 424 000 Common Stock
INSIDER POWER
52.80
Last 97 transactions
Buy: 26 530 299 | Sell: 8 848 103

Forecast: 01:40 - $1.036

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.881 (-8.00% )
Volume 2.76 mill
Avg. Vol. 0.634 mill
% of Avg. Vol 435.52 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Selecta Biosciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Selecta Biosciences Inc

RSI

Intraday RSI14 chart for Selecta Biosciences Inc

Last 10 Buy & Sell Signals For SELB

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Selecta Biosciences Inc

SELB

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising SEL-313, a product candidate in preclinical stage to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to evaluate the appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and products for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat primary biliary cholangitis and other autoimmune diseases. The company has license and collaboration agreements with Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum; Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Ginkgo Bioworks Holdings, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.

Last 10 Buy Signals

Date Signal @
UNFIUSDMar 29 - 11:417.52
ORDIUSDMar 29 - 11:4163.65
FXSUSDMar 29 - 11:41$7.73
AUDIOUSDMar 29 - 11:40$0.308
PROPCUSDMar 29 - 11:414.36
GRAILUSDMar 29 - 11:412 214.61
TIMEUSDMar 29 - 11:4032.43
SXPUSDMar 29 - 11:40$0.502
MBOXUSDMar 29 - 11:400.463
LSKUSDMar 29 - 11:40$1.980

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.